Literature DB >> 21970411

HIV as a chronic disease considerations for service planning in resource-poor settings.

Lucy Reynolds1.   

Abstract

This paper reviews the healthcare issues facing nations which have a substantial caseload of chronic HIV cases. It considers the challenges of extending antiretroviral coverage to an expanding caseload as supplier price rises and international trade agreements come into force to reduce the availability of affordable antiretrovirals just as the economic downturn restricts donor funding. It goes on to review the importance in this context of supporting adherence to drug regimens in order to preserve access to affordable antiretrovirals for those already on treatment, and of removing key barriers such as patient fees and supply interruptions. The demands of those with chronic HIV for health services other than antiretroviral therapy are considered in the light of the fearful or discriminatory attitudes of non-specialist healthcare staff due to HIV-related stigma, which is linked with the weakness of infection control measures in many health facilities. The implications for prevention strategies including those involving criminalisation of HIV transmission or exposure are briefly summarised for the current context, in which the caseload of those whose chronic HIV infection must be controlled with antiretrovirals will continue to rise for the foreseeable future.

Entities:  

Year:  2011        PMID: 21970411      PMCID: PMC3197478          DOI: 10.1186/1744-8603-7-35

Source DB:  PubMed          Journal:  Global Health        ISSN: 1744-8603            Impact factor:   4.185


  32 in total

Review 1.  Economic reform and health sector policy: lessons from structural adjustment programs.

Authors:  J W Peabody
Journal:  Soc Sci Med       Date:  1996-09       Impact factor: 4.634

Review 2.  Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review.

Authors:  Katharina Kranzer; Nathan Ford
Journal:  Trop Med Int Health       Date:  2011-07-01       Impact factor: 2.622

3.  Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.

Authors:  Russell B Van Dyke; Sophia Lee; George M Johnson; Andrew Wiznia; Kathleen Mohan; Kenneth Stanley; Edward V Morse; Paul A Krogstad; Sharon Nachman
Journal:  Pediatrics       Date:  2002-04       Impact factor: 7.124

4.  Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy.

Authors:  J Byakika-Tusiime; J H Oyugi; W A Tumwikirize; E T Katabira; P N Mugyenyi; D R Bangsberg
Journal:  Int J STD AIDS       Date:  2005-01       Impact factor: 1.359

5.  Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania.

Authors:  Habib O Ramadhani; Nathan M Thielman; Keren Z Landman; Evaline M Ndosi; Feng Gao; Jennifer L Kirchherr; Rekha Shah; Humphrey J Shao; Susan C Morpeth; Jonathan D McNeill; John F Shao; John A Bartlett; John A Crump
Journal:  Clin Infect Dis       Date:  2007-10-22       Impact factor: 9.079

6.  Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa.

Authors:  David Stead; Meg Osler; Andrew Boulle; Kevin Rebe; Graeme Meintjes
Journal:  Antivir Ther       Date:  2008

7.  Understanding and measuring AIDS-related stigma in health care settings: a developing country perspective.

Authors:  V S Mahendra; L Gilborn; S Bharat; R Mudoi; I Gupta; B George; L Samson; C Daly; J Pulerwitz
Journal:  SAHARA J       Date:  2007-08

8.  HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy.

Authors:  Andy I Choi; Michael G Shlipak; Peter W Hunt; Jeffrey N Martin; Steven G Deeks
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

9.  The impact of utilizing HIV-positive speakers in AIDS education.

Authors:  Susan Paxton
Journal:  AIDS Educ Prev       Date:  2002-08

10.  Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial.

Authors:  Shabbar Jaffar; Barbara Amuron; Susan Foster; Josephine Birungi; Jonathan Levin; Geoffrey Namara; Christine Nabiryo; Nicaise Ndembi; Rosette Kyomuhangi; Alex Opio; Rebecca Bunnell; Jordan W Tappero; Jonathan Mermin; Alex Coutinho; Heiner Grosskurth
Journal:  Lancet       Date:  2009-11-24       Impact factor: 79.321

View more
  2 in total

1.  'Dented' and 'resuscitated' masculinities: the impact of HIV diagnosis and/or enrolment on antiretroviral treatment on masculine identities in rural eastern Uganda.

Authors:  Godfrey E Siu; Daniel Wight; Janet Seeley
Journal:  SAHARA J       Date:  2014

2.  Improving fold resistance prediction of HIV-1 against protease and reverse transcriptase inhibitors using artificial neural networks.

Authors:  Olivier Sheik Amamuddy; Nigel T Bishop; Özlem Tastan Bishop
Journal:  BMC Bioinformatics       Date:  2017-08-15       Impact factor: 3.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.